ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is bluebird bio, Inc. ?
1
Weak Long Term Fundamental Strength- the stock has also not traded in the last 9 days
- Poor long term growth as Net Sales has grown by an annual rate of 13.97% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -384.48
2
Positive results in Mar 25
- RAW MATERIAL COST(Y) Fallen by -217.51% (YoY)
- NET SALES(Q) Highest at USD 38.71
- OPERATING PROFIT(Q) Highest at USD -5.96
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 0%, its profits have risen by 34.2%
4
Reducing Promoter Confidence
- Promoters have decreased their stake in the company by -1.47% over the previous quarter and currently hold 1.09% of the company
- Promoters decreasing their stake may signify reduced confidence in the future of the business
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to bluebird bio, Inc. should be less than 10%
- Overall Portfolio exposure to Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is bluebird bio, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
bluebird bio, Inc.
-72.25%
-0.46
161.53%
S&P 500
13.68%
0.61
20.23%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.97%
EBIT Growth (5y)
11.86%
EBIT to Interest (avg)
-384.48
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.22
Sales to Capital Employed (avg)
0.25
Tax Ratio
0.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
75.93%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.84
EV to EBIT
-0.56
EV to EBITDA
-0.80
EV to Capital Employed
9.41
EV to Sales
1.14
PEG Ratio
NA
Dividend Yield
2008.21%
ROCE (Latest)
-1666.78%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for bluebird bio, Inc.
Net Sales
At USD 38.71 MM has Grown at 84.77%
over average net sales of the previous four periods of USD 20.95 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Net Sales
Highest at USD 38.71 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD -5.96 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -15.41 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD -25.87 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -25.87 MM has Grown at 56.53%
over average net sales of the previous four periods of USD -59.5 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -25.97 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD -25.97 MM has Grown at 56.37%
over average net sales of the previous four periods of USD -59.52 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by -217.51% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for bluebird bio, Inc.
Interest
At USD 11.45 MM has Grown at 28.94%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Cash and Eqv
Lowest at USD 141.12 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 1.61%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
